DE69941815D1 - Verfahren für die quantitative freisetzung von natürlichen oder rekombinanten proteinen, polypeptiden oder peptiden - Google Patents

Verfahren für die quantitative freisetzung von natürlichen oder rekombinanten proteinen, polypeptiden oder peptiden

Info

Publication number
DE69941815D1
DE69941815D1 DE69941815T DE69941815T DE69941815D1 DE 69941815 D1 DE69941815 D1 DE 69941815D1 DE 69941815 T DE69941815 T DE 69941815T DE 69941815 T DE69941815 T DE 69941815T DE 69941815 D1 DE69941815 D1 DE 69941815D1
Authority
DE
Germany
Prior art keywords
polypeptides
natural
recombinant proteins
peptides
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69941815T
Other languages
German (de)
English (en)
Inventor
Franz Steindl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Life Sciences Solutions USA LLC
Original Assignee
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Bio Sciences Corp filed Critical GE Healthcare Bio Sciences Corp
Application granted granted Critical
Publication of DE69941815D1 publication Critical patent/DE69941815D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/961Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/825Pretreatment for removal of interfering factors from sample
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/826Additives, e.g. buffers, diluents, preservatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
DE69941815T 1998-06-19 1999-05-14 Verfahren für die quantitative freisetzung von natürlichen oder rekombinanten proteinen, polypeptiden oder peptiden Expired - Lifetime DE69941815D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT106898 1998-06-19
PCT/SE1999/000828 WO1999066325A1 (en) 1998-06-19 1999-05-14 Method for the quantitative release of natural or recombinant proteins, polypeptides or peptides

Publications (1)

Publication Number Publication Date
DE69941815D1 true DE69941815D1 (de) 2010-01-28

Family

ID=3505919

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69941815T Expired - Lifetime DE69941815D1 (de) 1998-06-19 1999-05-14 Verfahren für die quantitative freisetzung von natürlichen oder rekombinanten proteinen, polypeptiden oder peptiden

Country Status (7)

Country Link
US (1) US6706486B1 (enExample)
EP (1) EP1088227B1 (enExample)
JP (1) JP4399115B2 (enExample)
AT (1) ATE452337T1 (enExample)
DE (1) DE69941815D1 (enExample)
ES (1) ES2337639T3 (enExample)
WO (1) WO1999066325A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003194775A (ja) 2001-12-28 2003-07-09 Japan Science & Technology Corp タンパク質の電気泳動法
JPWO2008078809A1 (ja) * 2006-12-27 2010-04-30 独立行政法人科学技術振興機構 鳥類抗体を使用する免疫学的検出方法
EP2529228A4 (en) * 2010-01-26 2013-09-04 Obschestvo S Ogranichennoi Otvetstvennostyu N Proizv Materia Medika Kholding Fa METHOD FOR DETERMINING THE LEVEL OF AUTOANTIBODIES BY IMMUNOENZYMATIC TESTING

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092114A (en) 1976-10-20 1978-05-30 Fisher Scientific Company Indirect latex test for determination of immunoglobulins
SE448190B (sv) 1985-06-03 1987-01-26 Pharmacia Ab Sett att bestemma fc-dels-bindande bakteriella polypeptider
EP0338591A3 (en) 1988-04-21 1991-09-04 Microprobe Corporation Nucleic acid extraction method
AU693836B2 (en) 1993-11-29 1998-07-09 Gen-Probe Incorporated Method for extracting nucleic acids from a wide range of organisms
US5556745A (en) 1994-06-03 1996-09-17 Sch+E,Uml U+Ee Pbach; J+E,Uml O+Ee Rg Method for the detection and quantitative determination of antigen in a test sample containing immune complexes of antigen bound to antibodies and to rheumatoid factors
AT403378B (de) 1995-09-11 1998-01-26 Steindl Franz Dipl Ing Dr Immun- und proteinkomplex-dissoziierung

Also Published As

Publication number Publication date
ES2337639T3 (es) 2010-04-27
EP1088227B1 (en) 2009-12-16
US6706486B1 (en) 2004-03-16
ATE452337T1 (de) 2010-01-15
JP2002518675A (ja) 2002-06-25
EP1088227A1 (en) 2001-04-04
JP4399115B2 (ja) 2010-01-13
WO1999066325A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
ES8405156A1 (es) Procedimiento para la produccion de equipos de analisis inmulogicos.
DE69624920D1 (de) Testreagentien und Testvorrichtungen
ES8800435A1 (es) Un metodo de inmunoensayo.
ATE169409T1 (de) Positive und positive/negative zellselektion vermittelt durch peptiofreisetzung
DE69232832D1 (de) Bindungsdomänen in notch- und delta-proteinen
ATE290212T1 (de) Immunologische bestimmungen von prostata- spezifischem antigen
DE3877617D1 (de) Verfahren zum erreichen einer linearen normkurve in einem sandwich-immunoassay.
ATE12010T1 (de) Verfahren zur bestimmung von antigen-antikoerper- reaktionen und reagens hierfuer.
EP0174652A3 (en) Immunochemical test process for hapteus and proteins
ATE93060T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel.
KR920006005A (ko) 인체 IgE에 대한 모노클론 항체
JPH0368868A (ja) 蛋白質分析物の酸化的変性
DE69941815D1 (de) Verfahren für die quantitative freisetzung von natürlichen oder rekombinanten proteinen, polypeptiden oder peptiden
DE60323105D1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
KR910019642A (ko) B형 간염 바이러스 외피의 PreS2및 PreS1 폴리펩티드에 대한 모노클로날 항체
ATE57016T1 (de) Immunologische bestimmungsmethode zum nachweis von fc-teilbinden bakteriellen polypeptiden und/oder entsprechenden antikoerpern.
DE59309215D1 (de) Verfahren zur Bestimmung von Antigenen oder Antikörpern in Gegenwart eines Immunkomplexes
KR950014137A (ko) 당복합체의 측정방법 및 시약
Rejnek et al. The proteins in Lumbricus terrestris and Eisenia foetida coelomic fluids and on coelomocytes reacting with sheep and goat IgG molecules
ATE143146T1 (de) Verfahren und reagenz zur bestimmung des follikel stimulierenden hormons sowie hierzu geeignete monoklonale antikörper
Vaerman et al. Secretory component of the guinea-pig
ATE40475T1 (de) Verbesserter immunoassay zur bestimmung von antikoerpern gegen native-dna.
Jenny et al. [23] Immunochemical techniques for studying coagulation proteins
DE59007046D1 (de) Verfahren zum Nachweis von Analyten.
Edwards et al. The Derivatization of Polystyrene and Nylon Beads. A Controlled Introduction of Functional Groups for Immobilization of Antibody Protein.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition